IP Library › Granted Patent US 8,377,995
Granted Patent B2
US 8,377,995 · App. 12/743,871 · Granted Feb 19, 2013

Orally disintegrating tablet

Inventors: Yuki Ikeda (Ibaraki, JP); Yasushi Ochiai (Ibaraki, JP)
Assignee: Dainippon Sumitomo Pharma Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,377,995
App. No.
12/743,871
Granted
Feb 19, 2013
Kind
B2
Abstract

The invention provides an orally disintegrating tablet that has both adequate tablet hardness and rapid disintegrability in the oral cavity, and that undergoes minor hardness reduction and maintains good oral disintegrability even when preserved under moist conditions. In particular, the invention relates to an orally disintegrating tablet containing (a) crystalline cellulose, (b) a calcium hydrogen phosphate compound, (c) a natural starch and (d) a lubricant, wherein the blending ratio to 100 wt % of the disintegrating tablet is (a) 9 to 60 wt %, (b) 16 to 60 wt %, (c) 3 to 40 wt % and (d) 0.01 to 1.8 wt %.

Claims (15)

1. An orally disintegrating tablet comprising (a) crystalline cellulose, (b) a calcium hydrogen phosphate compound, (c) a natural starch and (d) a lubricant, wherein the blending ratio is (a) 9 to 60 wt %, (b) 30 to 60 wt %, (c) 3 to 40 wt % and (d) 0.01 to 1.8 wt %, relative to 100 wt % of the disintegrating tablet, wherein the disintegrating tablet has an absolute hardness of not less than 1.0 N/mm 2 and an oral disintegration time of within 30 seconds when the disintegrating tablet is stored for 3 days at 40° C. and a relative humidity of 75%.

2. The orally disintegrating tablet according to claim 1 , wherein the blending ratio of the crystalline cellulose (a) is 9 to 53 wt %, and the blending ratio of the natural starch (c) is 3 to 30 wt %.

3. The orally disintegrating tablet according to claim 1 , wherein the tablet further comprises an efficacy ingredient (e) at a blending ratio of 0.01 to 60 wt %.

4. The orally disintegrating tablet according to claim 1 , wherein the tablet further comprises one or more additives selected from the group consisting of fillers, binders, sweetening agents, taste correctives/odor correctives, fragrances, fluidizing agents, antistatic agents, coloring agents and coating agents.

5. The orally disintegrating tablet according to claim 3 , wherein the tablet consists essentially of crystalline cellulose (a), a calcium hydrogen phosphate compound (b), a natural starch (c), a lubricant (d) and an efficacy ingredient (e).

6. The orally disintegrating tablet according to claim 3 , wherein the tablet is obtained by adding a lubricant (d) to a composition obtained by blending crystalline cellulose (a), a calcium hydrogen phosphate compound (b) and a natural starch (c), each of which is in a powder or granular form, and an efficacy ingredient (e), and compression-molding the composition.

7. The orally disintegrating tablet according to claim 1 , wherein the tablet is produced by compression molding by direct tableting.

8. The orally disintegrating tablet according to claim 1 , wherein the blending ratio of the crystalline cellulose (a) is 20 to 53 wt %.

9. The orally disintegrating tablet according to claim 1 , wherein the blending ratio of the natural starch (c) is 9 to 30 wt %.

10. The orally disintegrating tablet according to claim 1 , wherein the blending ratio of the lubricant (d) is 0.01 to 1.0 wt %.

11. The orally disintegrating tablet according to claim 4 , wherein the blending ratio of the additive is 0.01 to 40 wt %.

12. The orally disintegrating tablet according to claim 1 , wherein the natural starch (c) is at least one kind selected from the group consisting of corn starch, wheat starch, rice starch and potato starch.

13. The orally disintegrating tablet according to claim 12 , wherein the natural starch (c) is corn starch.

14. The orally disintegrating tablet according to claim 1 , wherein the lubricant (d) is at least one kind selected from the group consisting of stearic acid, calcium stearate, sodium stearyl fumarate, talc, light anhydrous silicic acid and magnesium stearate.

15. The orally disintegrating tablet according to claim 14 , wherein the lubricant (d) is magnesium stearate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2010
From: IKEDA, YUKI; OCHIAI, YASUSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 024416/0287 →
Priority Claims (1)
JP 2007-302284 · Nov 21, 2007 · national
Continuity (1)
Related Publication 20100286286A1 · Nov 11, 2010